<DOC>
	<DOCNO>NCT00339612</DOCNO>
	<brief_summary>This observational , prospective cohort study describe demographic , clinical , immunologic , virologic characteristic HIV-infected child participate clinical site Latin American country . Enrollment study consist approximately 500 HIV-infected child two cohort acquire HIV infection mother-to-child transmission ( MTCT ) . The first group static cohort consist HIV-infected child five year age younger previously enrol NISDI Pediatric Protocol . The second cohort dynamic cohort prospectively enrol , HIV-infected child five year age younger . We characterize complication disease treatment . Subjects evaluate every six month approximately five year assessments growth , morbidity , disease progression mortality make .</brief_summary>
	<brief_title>NISDI Pediatric Latin American Countries Epidemiologic Study ( PLACES ) : A Prospective Observational Study HIV-Infected Children Clinical Sites Latin American Countries</brief_title>
	<detailed_description>This observational , prospective cohort study describe demographic , clinical , immunologic , virologic characteristic HIV-infected child participate clinical site Latin American country . Enrollment study consist approximately 500 HIV-infected child two cohort acquire HIV infection mother-to-child transmission ( MTCT ) . The first group static cohort consist HIV-infected child five year age younger previously enrol NISDI Pediatric Protocol . The second cohort dynamic cohort prospectively enrol , HIV-infected child five year age younger . We characterize complication disease treatment . Subjects evaluate every six month approximately five year assessments growth , morbidity , disease progression mortality make .</detailed_description>
	<criteria>INCLUSION CRITERIA : Static Cohort : 1 . Previous participation NISDI Protocol 2 . Less 6 year age ( 6th birthday ) time enrollment NISDI Pediatric Protocol 3 . HIVinfected 4 . HIV infection must document medical record : 1 . For child le 18 month old test , two follow ( separate determination separate blood specimen ) : Positive HIV culture Positive HIV DNA PCR Positive neutralizable p24 antigen Quantitative HIV RNA great equal 10,000 copies/ml 2 . For child great equal 18 month old test , two follow ( separate determination separate blood specimen ) : Reactive test HIV antibody sample obtain great equal 15 month age confirmatory test Western Blot Immunofluorescence assay Positive HIV culture Positive HIV DNA PCR Positive neutralizable p24 antigen Quantitative HIV RNA great equal 1,000 copies/ml 5 . Documentation maternal HIV infection country appropriate National Guidelines 6 . Signed informed consent parent legal guardian . An informed assent document provide child 8 year age old appropriate . 7 . Subjects must able follow participate clinical site . 8 . Subjects may coenrolled clinical trial treatment HIV infection , opportunistic infection , HIVrelated effect . Dynamic cohort : 1 . HIVinfected less 6 year age ( 6th birthday ) enrollment protocol 2 . HIV infection document : 1 . For child &lt; 18 month old test , two follow ( separate determination separate blood specimen ) : Positive HIV culture Positive HIV DNA PCR Positive neutralizable p24 antigen Quantitative HIV RNA great equal 10,000 copies/ml 2 . For child great equal 18 month old test , two follow ( separate determination separate blood specimen ) : Reactive test HIV antibody sample obtain great equal 15 month age confirmatory test Western Blot Immunofluorescence assay Positive HIV culture Positive HIV DNA PCR Positive neutralizable p24 antigen Quantitative HIV RNA great equal 1,000 copies/ml 3 . Documentation maternal HIV infection country appropriate National Guidelines 4 . Signed informed consent parent legal guardian . An informed assent document provide child 8 year age old appropriate . 5 . Subjects must able follow participate clinical site 6 . Subjects may co enrolled clinical trial treatment HIV infection , opportunistic infection , HIV relate effect EXCLUSION CRITERIA : 1 . Children born HIV infect mother , uninfected indeterminate HIV infection status 2 . Children orphan without legal guardian ward state</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>August 25, 2016</verification_date>
	<keyword>Perinatal</keyword>
	<keyword>HIV</keyword>
	<keyword>AIDS</keyword>
</DOC>